Cargando…

How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding

BACKGROUND: Antimicrobial use data are increasingly available, yet it is not clear how to use them most effectively. An understanding of how practice decisions influence antimicrobial use may aid individual knowledge development and rational policy planning. We developed a mathematical model to desc...

Descripción completa

Detalles Bibliográficos
Autores principales: Jones, Makoto, Khader, Karim, Huttner, Benedikt, Graber, Christopher, Zhang, Yue, Samore, Matthew, Madaras-Kelly, Karl, Goetz, Matthew, Glassman, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632113/
http://dx.doi.org/10.1093/ofid/ofx163.538
_version_ 1783269635219521536
author Jones, Makoto
Khader, Karim
Huttner, Benedikt
Graber, Christopher
Zhang, Yue
Samore, Matthew
Madaras-Kelly, Karl
Goetz, Matthew
Glassman, Peter
author_facet Jones, Makoto
Khader, Karim
Huttner, Benedikt
Graber, Christopher
Zhang, Yue
Samore, Matthew
Madaras-Kelly, Karl
Goetz, Matthew
Glassman, Peter
author_sort Jones, Makoto
collection PubMed
description BACKGROUND: Antimicrobial use data are increasingly available, yet it is not clear how to use them most effectively. An understanding of how practice decisions influence antimicrobial use may aid individual knowledge development and rational policy planning. We developed a mathematical model to describe antimicrobial use and demonstrate how it could be used in a model-driven decision support system. METHODS: We developed a discrete-time Markov chain model to describe antimicrobial use as a function of the following parameters: Choice decisions to start antibiotics on admission or after, Change decisions to stop antibiotics, and Completion decisions to discharge patients whether they were on or off antimicrobials. Partial derivatives were used to predict the extent to which antimicrobial use would respond to changes in each parameter. We used Veterans Affairs Bar Code Medication Administration data from 2010 to estimate parameters, as well as antimicrobial use using National Healthcare Safety Network (NHSN) definitions. Categories of anti-methicillin-resistant Staphylococcus aureus (MRSA), broad community, broad hospital, and surgical site infection prophylaxis (SSIP) from NHSN were also used. Because of certain assumptions made when estimating parameters, we used non-linear regression to adjust them using data from year 2010. We then applied our model to predict antimicrobial use from 2013 parameters and compared with actual use with Pearson’s correlation coefficient. RESULTS: Correlation of predicted and actual antimicrobial use was 0.97, 0.99, 0.95, and 0.92 (using NHSN category order above; Figure 1). As a conservative estimate, the correlation of yearly changes between predicted and actual antimicrobial use for all categories was 0.75. For > 99% of all combinations of medical center, antimicrobial category, and year, decreasing the probability of starting antimicrobials had the most impact on measured antimicrobial use. CONCLUSION: Our mathematical model is highly predictive of antimicrobial use and can be used to anticipate how much changes in decision points might lead to changes in antimicrobial use. Given the parameter space that most VA medical centers occupy, not starting antimicrobials appears to have greatest impact on use. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-5632113
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-56321132017-11-07 How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding Jones, Makoto Khader, Karim Huttner, Benedikt Graber, Christopher Zhang, Yue Samore, Matthew Madaras-Kelly, Karl Goetz, Matthew Glassman, Peter Open Forum Infect Dis Abstracts BACKGROUND: Antimicrobial use data are increasingly available, yet it is not clear how to use them most effectively. An understanding of how practice decisions influence antimicrobial use may aid individual knowledge development and rational policy planning. We developed a mathematical model to describe antimicrobial use and demonstrate how it could be used in a model-driven decision support system. METHODS: We developed a discrete-time Markov chain model to describe antimicrobial use as a function of the following parameters: Choice decisions to start antibiotics on admission or after, Change decisions to stop antibiotics, and Completion decisions to discharge patients whether they were on or off antimicrobials. Partial derivatives were used to predict the extent to which antimicrobial use would respond to changes in each parameter. We used Veterans Affairs Bar Code Medication Administration data from 2010 to estimate parameters, as well as antimicrobial use using National Healthcare Safety Network (NHSN) definitions. Categories of anti-methicillin-resistant Staphylococcus aureus (MRSA), broad community, broad hospital, and surgical site infection prophylaxis (SSIP) from NHSN were also used. Because of certain assumptions made when estimating parameters, we used non-linear regression to adjust them using data from year 2010. We then applied our model to predict antimicrobial use from 2013 parameters and compared with actual use with Pearson’s correlation coefficient. RESULTS: Correlation of predicted and actual antimicrobial use was 0.97, 0.99, 0.95, and 0.92 (using NHSN category order above; Figure 1). As a conservative estimate, the correlation of yearly changes between predicted and actual antimicrobial use for all categories was 0.75. For > 99% of all combinations of medical center, antimicrobial category, and year, decreasing the probability of starting antimicrobials had the most impact on measured antimicrobial use. CONCLUSION: Our mathematical model is highly predictive of antimicrobial use and can be used to anticipate how much changes in decision points might lead to changes in antimicrobial use. Given the parameter space that most VA medical centers occupy, not starting antimicrobials appears to have greatest impact on use. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2017-10-04 /pmc/articles/PMC5632113/ http://dx.doi.org/10.1093/ofid/ofx163.538 Text en © The Author 2017. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Jones, Makoto
Khader, Karim
Huttner, Benedikt
Graber, Christopher
Zhang, Yue
Samore, Matthew
Madaras-Kelly, Karl
Goetz, Matthew
Glassman, Peter
How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title_full How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title_fullStr How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title_full_unstemmed How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title_short How to Use Antimicrobial Use Data? A Model to Support Decision-Making and Facilitate Understanding
title_sort how to use antimicrobial use data? a model to support decision-making and facilitate understanding
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5632113/
http://dx.doi.org/10.1093/ofid/ofx163.538
work_keys_str_mv AT jonesmakoto howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT khaderkarim howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT huttnerbenedikt howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT graberchristopher howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT zhangyue howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT samorematthew howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT madaraskellykarl howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT goetzmatthew howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding
AT glassmanpeter howtouseantimicrobialusedataamodeltosupportdecisionmakingandfacilitateunderstanding